Mergers & Acquisitions
Feb. 19, 2014
Latham guides $25 billion pharma deal
Dublin-based drugmaker Actavis PLC tapped Latham & Watkins LLP to help guide its largest deal to date.
Daily Journal Staff Writer
Dublin-based drugmaker Actavis PLC tapped Latham & Watkins LLP to help guide its largest deal to date. On Tuesday, Actavis announced plans to acquire pharmaceutical developer Forest Laboratories Inc. for $25 billion in cash and stock - one of the biggest pharmaceutical deals in recent years.
Costa Mesa partners R. Scott Shean and Charles K. Ruck co-led the Latham team alongside New York partn...
To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In